“十四五”我国生物制造产业总规模达1.1万亿元

Core Insights - During the "14th Five-Year Plan" period, China's biomanufacturing industry has experienced significant growth in scale, technology, and cluster development, with a total scale reaching 1.1 trillion yuan [1][1][1] Industry Growth - The biomanufacturing industry in China has steadily expanded, with the production of biopharmaceutical products accounting for over 70% of the global output [1][1] - The annual output value of sub-sectors such as food additives and biopharmaceuticals exceeds 400 billion yuan, establishing biomanufacturing as a new economic growth point [1][1] Technological Innovation - China's biomanufacturing sector holds over 20% of the global patent application share, indicating significant innovation capabilities [1][1] - A number of national key laboratories and industrial innovation platforms have been established, leading to the industrial application of new instruments such as domestic high-throughput gene sequencers and large-scale fermentation tanks [1][1] Industry Clusters - Regions like Beijing and Tianjin have emerged as innovation hubs for biomanufacturing, while Shandong, Heilongjiang, and Henan have developed into major manufacturing bases for bulk biopharmaceutical products [1][1] - Cities such as Chongqing and Guangdong are continuously producing original achievements in the field [1][1] - The industry has nurtured several backbone enterprises with annual revenues exceeding 10 billion yuan, along with dozens of national-level manufacturing champions and specialized "little giant" enterprises [1][1]